00000000|MMI|3.65|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|89/14|
00000000|MMI|3.65|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|89/14|
00000000|MMI|3.65|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|116/13|
00000000|MMI|3.59|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-1-"PUO"-noun-0]|TX|12/3|
00000000|MMI|3.46|10%|C3842590|[fndg]|["10%"-tx-1-"10"-fraction-0]|TX|105/2|
00000000|MMI|3.46|Clinical act of insertion|C0441587|[hlca]|["Placement"-tx-1-"placement"-noun-0]|TX|69/9|
00000000|MMI|3.46|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|83/3|
00000000|MMI|3.46|Discontinued|C1444662|[fndg]|["DIS"-tx-1-"DIS"-noun-0]|TX|83/3|
00000000|MMI|3.46|Placement|C1524072|[qlco]|["Placement"-tx-1-"placement"-noun-0]|TX|69/9|
00000000|MMI|3.46|Placement action|C1533810|[hlca]|["Placement"-tx-1-"placement"-noun-0]|TX|69/9|
00000000|MMI|3.46|ppm|C0439187|[qnco]|["PPM"-tx-1-"PPM"-noun-0]|TX|65/3|
00000000|MMI|119.64|Mongolia|C0026410|[geoa]|["MG"-tx-3-"MG"-noun-0,"MG"-tx-2-"MG"-noun-0]|TX|869/2;[381/2],[417/2],[451/2],[486/2],[614/2],[694/2],[747/2]|Z01.252.474.651
00000000|MMI|101.70|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-15-"DISCHARGE"-noun-0,"Discharge"-tx-14-"DISCHARGE"-noun-0,"Discharge"-tx-3-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0,"Patient Discharge"-tx-1-"DISCHARGE PATIENT"-noun-0]|TX|2580/9;2403/9;1131/9;33/9;116/17|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|75.98|Portugal|C0032729|[geoa]|["PO"-tx-3-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|872/2;[384/2],[420/2],[454/2],[617/2],[697/2],[750/2]|Z01.542.727
00000000|MMI|61.19|Aspirin|C0004057|[orch,phsu]|["ASA"-tx-10-"asa"-noun-0,"ASPIRIN"-tx-2-"ASPIRIN"-noun-0]|TX|2256/3;352/7|D02.455.426.559.389.657.410.595.176
00000000|MMI|48.50|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-3-"DIAGNOSIS"-noun-0]|TX|[1106/9],[1220/9]|x.x.x.x.x.x.x
00000000|MMI|45.31|Pentoxifylline|C0030899|[orch,phsu]|["PTX"-tx-8-"PTX"-noun-0,"PTX"-tx-6-"PTX"-noun-0]|TX|2179/3;1979/3|D03.438.759.758.824.651.700
00000000|MMI|45.09|Coding|C0009219|[ocac]|["code"-tx-2-"CODE"-noun-0,"code"-tx-2-"code"-noun-0]|TX|280/4;298/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|39.60|Rabbi|C0684010|[prog]|["R."-tx-8-"r"-adj-0,"R."-tx-5-"r"-noun-0,"R."-tx-3-"R"-noun-0]|TX|2175/1;1889/1;1550/1|M01.526.799.500
00000000|MMI|33.06|ppm|C0439187|[qnco]|["PPM"-tx-8-"PPM"-noun-0,"PPM"-tx-7-"PPM"-noun-0,"PPM"-tx-5-"PPM"-noun-0,"PPM"-tx-4-"PPM"-noun-0,"PPM"-tx-3-"PPM"-noun-0]|TX|2069/3;2053/3;1930/3;1773/3;[1200/3],[1470/3],[1597/3],[1729/3]|
00000000|MMI|32.04|Daily|C0332173|[tmco]|["Daily"-tx-5-"DAILY"-adj-0,"QD"-tx-3-"QD"-noun-0,"QD"-tx-2-"QD"-noun-0]|TX|1794/5;[875/2],[913/2];[387/2],[423/2],[457/2],[700/2],[753/2]|
00000000|MMI|31.98|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-3-"MG"-noun-0,"Mg++"-tx-2-"MG"-noun-0]|TX|869/2;[381/2],[417/2],[451/2],[486/2],[614/2],[694/2],[747/2]|
00000000|MMI|31.98|Milligram percent|C1960952|[qnco]|["mg %"-tx-3-"MG"-noun-0,"mg %"-tx-2-"MG"-noun-0]|TX|869/2;[381/2],[417/2],[451/2],[486/2],[614/2],[694/2],[747/2]|
00000000|MMI|31.98|mg/dL|C0439269|[qnco]|["mg%"-tx-3-"MG"-noun-0,"mg%"-tx-2-"MG"-noun-0]|TX|869/2;[381/2],[417/2],[451/2],[486/2],[614/2],[694/2],[747/2]|
00000000|MMI|27.26|Cephalexin|C0007716|[antb,orch]|["Cefalexin"-tx-2-"CEPHALEXIN"-noun-0]|TX|469/10|D02.065.589.099.249.200;D02.886.665.074.200;D04.075.080.875.099.221.249.200
00000000|MMI|27.26|Sertraline|C0074393|[orch,phsu]|["SERTRALINE"-tx-2-"SERTRALINE"-noun-0]|TX|435/10|D02.092.705.800;D02.455.426.559.847.638.845.800;D04.615.638.845.800
00000000|MMI|26.87|Oral|C0442027|[spco]|["PO"-tx-3-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|872/2;[384/2],[420/2],[454/2],[617/2],[697/2],[750/2]|
00000000|MMI|26.13|Christmas Island|C0006888|[geoa]|["CXR"-tx-8-"cxr"-noun-0,"CXR"-tx-6-"CXR"-noun-0]|TX|2168/3;1962/3|Z01.639.100;Z01.678.100.373
00000000|MMI|26.13|Panama|C0030266|[geoa]|["PM"-tx-15-"PM"-noun-0,"PM"-tx-1-"PM"-adj-0]|TX|2563/2;155/2|Z01.107.169.772
00000000|MMI|26.05|Bradycardia|C0428977|[patf]|["BRADYCARDIA"-tx-7-"BRADYCARDIA"-noun-0,"BRADYCARDIA"-tx-3-"bradycardia"-noun-0]|TX|2037/11;1759/11|C14.280.067.319;C23.550.073.300
00000000|MMI|25.68|Zoloft|C0284660|[orch,phsu]|["Zoloft"-tx-2-"ZOLOFT"-noun-0]|TX|426/6|D02.092.705.800;D02.455.426.559.847.638.845.800;D04.615.638.845.800
00000000|MMI|24.11|Cerebroside-Sulfatase|C0007804|[aapp,enzy]|["ASA"-tx-10-"asa"-noun-0]|TX|2256/3|D08.811.277.352.827.070.250
00000000|MMI|24.11|Surgical aspects|C0038895|[ftcn]|["operations"-tx-3-"OPERATIONS"-noun-0]|TX|1443/10|x.x.x.x.x.x.x
00000000|MMI|24.11|Walking (activity)|C0080331|[dora]|["Walking"-tx-3-"Walking"-noun-0]|TX|1007/7|G11.427.590.530.568.900;G11.427.590.530.698.277.937;I03.350.937;I03.450.642.845.940
00000000|MMI|23.12|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-3-"HTN"-noun-0,"HYPERTENSION"-tx-3-"hypertension"-noun-0]|TX|1329/3;1335/12|C14.907.489
00000000|MMI|22.61|Antibiotics, Antitubercular|C0003237|[antb]|["Antibiotics"-tx-2-"ANTIBIOTICS"-noun-0]|TX|524/11|D27.505.954.122.085.255.135
00000000|MMI|22.61|Hydroxymethylglutaryl-CoA Reductase Inhibitors|C0360714|[orch,phsu]|["Statin"-tx-10-"statin"-noun-0]|TX|2271/6|D27.505.519.186.071.202.370;D27.505.519.389.370;D27.505.954.557.500.202.370
00000000|MMI|22.40|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-3-"Treatment"-noun-0]|TX|1282/9|x.x.x.x.x.x.x
00000000|MMI|20.95|Metoprolol|C0025859|[orch,phsu]|["METOPROLOL"-tx-2-"METOPROLOL"-noun-0]|TX|715/10|D02.033.100.624.698.573;D02.033.755.624.698.573;D02.092.063.624.698.573
00000000|MMI|20.30|Disease|C0012634|[dsyn]|["condition"-tx-14-"CONDITION"-noun-0,"condition"-tx-3-"Conditions"-noun-0]|TX|2413/9;1230/10|C23.550.288
00000000|MMI|20.16|Complication Aspects|C1171258|[patf]|["complications"-tx-3-"Complications"-noun-0,"complications"-tx-3-"complications"-noun-1]|TX|1256/13;1497/13|x.x.x
00000000|MMI|19.40|Toprol-XL|C0723783|[orch,phsu]|["Toprol XL"-tx-2-"TOPROL XL"-noun-0]|TX|703/9|D02.033.100.624.698.573;D02.033.755.624.698.573;D02.092.063.624.698.573
00000000|MMI|19.36|Meal (occasion for eating)|C1998602|[dora]|["Meals"-tx-2-"meals"-noun-0]|TX|813/5|F01.145.407.432.500;F01.145.466.349.500;G07.203.300.590;G07.203.650.353.432.500;J02.500.590
00000000|MMI|19.31|District of Columbia|C0012764|[geoa]|["D.C."-tx-1-"D/C"-noun-0]|TX|200/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|19.26|Po 12|C1569564|[orch,phsu]|["Po 12"-tx-2-"PO 12"-noun-0]|TX|489/2,498/2|D02.455.849.919.530.444
00000000|MMI|17.80|Barbados|C0004739|[geoa]|["BB"-tx-10-"bb"-noun-0]|TX|2280/2|Z01.107.084.900.140;Z01.639.880.140
00000000|MMI|17.80|Coronary Arteriosclerosis|C0010054|[dsyn]|["coronary artery disease"-tx-3-"coronary artery disease"-noun-0]|TX|1356/23|C14.280.647.250.260;C14.907.137.126.339;C14.907.585.250.260
00000000|MMI|17.80|Coronary Artery Disease|C1956346|[dsyn]|["CORONARY ARTERY DISEASE"-tx-3-"coronary artery disease"-noun-0]|TX|1356/23|C14.280.647.250.260;C14.907.137.126.339;C14.907.585.250.260
00000000|MMI|17.80|Diabetes Mellitus, Non-Insulin-Dependent|C0011860|[dsyn]|["Diabetes mellitus type 2"-tx-3-"diabetes mellitus type 2"-noun-0]|TX|1302/24|C18.452.394.750.149;C19.246.300
00000000|MMI|17.80|Drowsiness|C0013144|[fndg]|["SLEEPY"-tx-5-"sleepy"-adj-0]|TX|1834/6|F02.830.855.796;G11.561.600.815.754
00000000|MMI|17.80|Lipitor|C0593906|[orch,phsu]|["Lipitor"-tx-3-"LIPITOR"-noun-0]|TX|841/7|D03.383.129.578.075;D10.251.450.200
00000000|MMI|17.80|Lisinopril|C0065374|[aapp,phsu]|["Lysinopril"-tx-2-"LISINOPRIL"-noun-0]|TX|400/10|D12.644.456.345.600
00000000|MMI|17.80|Metformin|C0025598|[orch,phsu]|["METFORMIN"-tx-3-"METFORMIN"-noun-0]|TX|891/9|D02.078.370.141.450
00000000|MMI|17.80|Togo|C0040363|[geoa]|["TO"-tx-8-"to"-adv-0]|TX|2081/2|Z01.058.290.190.800
00000000|MMI|17.80|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-8-"to"-adv-0]|TX|2081/2|D08.811.520.224.800
00000000|MMI|16.37|Renal Insufficiency|C1565489|[dsyn]|["Renal dysfunction"-tx-3-"renal dysfunction"-noun-0]|TX|1396/17|C12.777.419.780;C13.351.968.419.780
00000000|MMI|16.34|Fat-Restricted Diet|C0242970|[topp]|["Low fat diet, NOS"-tx-3-"Low fat DIET"-noun-0]|TX|954/3,973/8|E02.642.249.260;G07.203.650.240.260
00000000|MMI|16.30|Antibiotics|C0003232|[antb]|["Antibiotics"-tx-2-"ANTIBIOTICS"-noun-0]|TX|524/11|D27.505.954.122.085
00000000|MMI|16.30|Patient observation|C0700325|[hlca]|["Observation"-tx-8-"observation"-noun-0]|TX|2154/11|N04.761.559.590.900
00000000|MMI|16.25|Pulse taking|C0034107|[hlca]|["Pulses"-tx-5-"pulses"-noun-0]|TX|1918/6|E01.370.370.380.650;E01.370.600.650;G09.330.380.750
00000000|MMI|16.22|Glucophage|C0591573|[orch,phsu]|["Glucophage"-tx-3-"GLUCOPHAGE"-noun-0]|TX|878/10|D02.078.370.141.450
00000000|MMI|16.22|Zestril|C0678140|[aapp,phsu]|["Zestril"-tx-2-"ZESTRIL"-noun-0]|TX|390/7|D12.644.456.345.600
00000000|MMI|16.22|Iodides|C0021966|[inch]|["I-"-tx-5-"I"-noun-0]|TX|1951/1|D01.248.497.158.490;D01.475.410
00000000|MMI|16.12|Ivory Coast|C0022326|[geoa]|["IV"-tx-2-"IV"-noun-0]|TX|521/2|Z01.058.290.190.272
00000000|MMI|16.10|Food-Drug Interactions|C0242785|[dsyn]|["Interaction, Food-Drug"-tx-2-"Food/Drug Interaction"-noun-0]|TX|756/21|G07.690.773.968.511
00000000|MMI|16.07|Glyburide|C0017628|[orch,phsu]|["GLYBURIDE"-tx-3-"GLYBURIDE"-noun-0]|TX|916/9|D02.886.590.795.575;D02.948.828.575
00000000|MMI|15.00|3+ Answer to Question|C3838680|[fndg]|["3+"-tx-15-"3"-fraction-0,"3+"-tx-11-"3"-integer-0,"3+"-tx-3-"3"-fraction-1,"3+"-tx-1-"3"-fraction-0]|TX|2547/1;2292/1;1481/1;138/1|
00000000|MMI|15.00|3+ Score|C2827736|[qnco]|["3+"-tx-15-"3"-fraction-0,"3+"-tx-11-"3"-integer-0,"3+"-tx-3-"3"-fraction-0,"3+"-tx-1-"3"-fraction-0]|TX|2547/1;2292/1;1481/1;138/1|
00000000|MMI|15.00|3+ Score, WHO|C2981702|[clas]|["3+"-tx-15-"3"-fraction-0,"3+"-tx-11-"3"-integer-0,"3+"-tx-3-"3"-fraction-0,"3+"-tx-1-"3"-fraction-0]|TX|2547/1;2292/1;1481/1;138/1|
00000000|MMI|15.00|<3 (qualifier value)|C0439086|[qnco]|["<3"-tx-15-"3"-fraction-0,"<3"-tx-11-"3"-integer-0,"<3"-tx-3-"3"-fraction-0,"<3"-tx-1-"3"-fraction-0]|TX|2547/1;2292/1;1481/1;138/1|
00000000|MMI|14.76|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-15-"DISCHARGE"-noun-0,"Discharge"-tx-14-"DISCHARGE"-noun-0,"Discharge"-tx-3-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|2580/9;2403/9;1131/9;33/9|
00000000|MMI|14.76|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-15-"DISCHARGE"-noun-0,"Discharge"-tx-14-"DISCHARGE"-noun-0,"Discharge"-tx-3-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|2580/9;2403/9;1131/9;33/9|
00000000|MMI|14.64|ARID1A protein, human|C0675390|[aapp,bacs]|["hELD"-tx-12-"held"-verb-0]|TX|2302/4|x.x.x.x
00000000|MMI|14.64|Coronary heart disease|C0010068|[dsyn]|["Coronary (artery) disease"-tx-3-"coronary artery disease"-noun-0]|TX|1356/23|C14.280.647.250;C14.907.585.250
00000000|MMI|14.64|Costa Rica|C0010182|[geoa]|["CRI"-tx-3-"CRI"-noun-0]|TX|1382/3|Z01.107.169.238
00000000|MMI|14.64|Dementia|C0497327|[mobd]|["-- Dementia"-tx-3-"dementia"-noun-0]|TX|1432/8|C10.228.140.380;F03.615.400
00000000|MMI|14.64|clopidogrel|C0070166|[orch,phsu]|["CLOPIDOGREL"-tx-2-"CLOPIDOGREL"-noun-0]|TX|677/11|x.x.x.x
00000000|MMI|14.51|Clinical act of insertion|C0441587|[hlca]|["Placement"-tx-7-"placement"-noun-0,"Placement"-tx-3-"placement"-noun-0]|TX|2057/9;[1204/9],[1601/9],[1733/9]|
00000000|MMI|14.51|Placement|C1524072|[qlco]|["Placement"-tx-7-"placement"-noun-0,"Placement"-tx-3-"placement"-noun-0]|TX|2057/9;[1204/9],[1601/9],[1733/9]|
00000000|MMI|14.51|Placement action|C1533810|[hlca]|["Placement"-tx-7-"placement"-noun-0,"Placement"-tx-3-"placement"-noun-0]|TX|2057/9;[1204/9],[1601/9],[1733/9]|
00000000|MMI|14.39|Home environment|C0442519|[cnce]|["house"-tx-12-"house"-adj-0,"HOME"-tx-10-"home"-noun-0,"house"-tx-3-"House"-noun-0,"HOME"-tx-2-"Home"-noun-0]|TX|2329/5;2232/4;946/5;316/4|
00000000|MMI|13.09|Algeria|C0002037|[geoa]|["DZ"-tx-3-"dz"-noun-0]|TX|1700/2|Z01.058.266.104
00000000|MMI|13.08|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-14-"PLAN"-noun-0]|TX|2437/4|C10.228.140.744
00000000|MMI|13.05|Cardiology discipline|C0007189|[bmod]|["Cardiology"-tx-14-"cardiology"-noun-0]|TX|2468/10|H02.403.429.163
00000000|MMI|13.05|Thailand|C0039725|[geoa]|["TH"-tx-3-"TH"-noun-0]|TX|1722/2|Z01.252.145.841
00000000|MMI|13.05|Thallium|C0039738|[elii]|["Th"-tx-3-"TH"-noun-0]|TX|1722/2|D01.268.556.847;D01.552.544.847;x.x.x.x
00000000|MMI|13.05|Diet|C0012155|[food]|["Diet"-tx-3-"DIET"-noun-0]|TX|940/4|G07.203.650.240
00000000|MMI|13.03|Stomach|C0038351|[bpoc]|["STOMACH"-tx-2-"stomach"-noun-0]|TX|831/7|A03.556.875.875
00000000|MMI|13.00|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-1-"D/C"-noun-0]|TX|200/3|E04.157.310;E04.950.300.299
00000000|MMI|12.93|PO-1|C0297198|[orch]|["PO-1"-tx-3-"PO 1"-noun-0]|TX|910/2,926/1|x.x.x.x
00000000|MMI|12.93|Comoros|C0009490|[geoa]|["CN"-tx-5-"cn"-noun-0]|TX|1863/2|Z01.639.520.200
00000000|MMI|12.93|Cyclic neutropenia|C0221023|[dsyn]|["CN"-tx-5-"cn"-noun-0]|TX|1863/2|x.x.x.x
00000000|MMI|12.93|Sodium|C0037473|[bacs,elii]|["SODIUM"-tx-3-"Sodium"-noun-0]|TX|990/6|D01.268.549.750;D01.268.557.650;D01.552.528.850;D01.552.547.725;x.x.x.x
00000000|MMI|12.90|Automobiles|C0004381|[mnob]|["Car"-tx-1-"CAR"-noun-0]|TX|112/3|J01.937.500.100
00000000|MMI|12.89|Evaluation|C0220825|[hlca]|["Evaluation"-tx-1-"evaluation"-noun-0]|TX|184/10|E05.337;N05.715.360.335
00000000|MMI|11.79|Order (action)|C1705178|[acty]|["Order"-tx-15-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|2590/6;204/5;43/6|
00000000|MMI|11.79|Order (arrangement)|C1705176|[qlco]|["Order"-tx-15-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|2590/6;204/5;43/6|
00000000|MMI|11.79|Order (document)|C1705175|[inpr]|["Order"-tx-15-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|2590/6;204/5;43/6|
00000000|MMI|11.79|Order (taxonomic)|C1705177|[clas]|["Order"-tx-15-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|2590/6;204/5;43/6|
00000000|MMI|11.79|Permutation|C1882348|[qlco]|["Order"-tx-15-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|2590/6;204/5;43/6|
00000000|MMI|11.79|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-15-"ORDERS"-verb-0,"ORDER"-tx-1-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|2590/6;204/5;43/6|
00000000|MMI|11.49|Allergy Specialty|C0002111|[bmod]|["Allergy"-tx-3-"ALLERGY"-noun-0]|TX|1087/7|H02.403.044
00000000|MMI|11.49|Methods aspects|C0025664|[inpr]|["procedures"-tx-3-"PROCEDURES"-noun-0]|TX|1458/10|x.x.x
00000000|MMI|11.12|1+|C3816745|[fndg]|["1+"-tx-6-"1"-integer-0,"1+"-tx-2-"1"-integer-0,"1+"-tx-1-"1"-fraction-0]|TX|2034/1;666/1;16/1|
00000000|MMI|11.12|1+ Score|C2827734|[qnco]|["1+"-tx-6-"1"-integer-0,"1+"-tx-2-"1"-integer-0,"1+"-tx-1-"1"-fraction-0]|TX|2034/1;666/1;16/1|
00000000|MMI|11.12|1+ Score, WHO|C2981698|[clas]|["1+"-tx-6-"1"-integer-0,"1+"-tx-2-"1"-integer-0,"1+"-tx-1-"1"-fraction-0]|TX|2034/1;666/1;16/1|
00000000|MMI|11.10|+2|C0740116|[qnco]|["+2"-tx-9-"2"-integer-0,"+2"-tx-3-"2"-fraction-0,"+2"-tx-3-"2"-integer-0]|TX|2186/1;[983/1],[1643/1];[983/1],[1643/1]|
00000000|MMI|11.10|2+|C3833492|[fndg]|["2+"-tx-9-"2"-integer-0,"2+"-tx-3-"2"-fraction-0,"2+"-tx-3-"2"-integer-0]|TX|2186/1;[983/1],[1643/1];[983/1],[1643/1]|
00000000|MMI|11.10|2+ Score|C2827735|[qnco]|["2+"-tx-9-"2"-integer-0,"2+"-tx-3-"2"-fraction-0,"2+"-tx-3-"2"-integer-0]|TX|2186/1;[983/1],[1643/1];[983/1],[1643/1]|
00000000|MMI|11.10|2+ Score, WHO|C2981700|[clas]|["2+"-tx-9-"2"-integer-0,"2+"-tx-3-"2"-fraction-0,"2+"-tx-3-"2"-integer-0]|TX|2186/1;[983/1],[1643/1];[983/1],[1643/1]|
00000000|MMI|10.76|R prime|C2603358|[clna]|["R'"-tx-8-"r"-adj-0,"R'"-tx-5-"r"-noun-0,"R'"-tx-3-"R"-noun-0]|TX|2175/1;1889/1;1550/1|
00000000|MMI|10.76|Right|C0205090|[spco]|["R-"-tx-8-"r"-adj-0,"R-"-tx-5-"r"-noun-0,"R-"-tx-3-"R"-noun-0]|TX|2175/1;1889/1;1550/1|
00000000|MMI|10.42|Approximate|C0332232|[qlco]|["Approximate"-tx-2-"approximate"-adj-0]|TX|[567/11],[651/11]|
00000000|MMI|10.42|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-3-"DIAGNOSIS"-noun-0]|TX|[1106/9],[1220/9]|E01
00000000|MMI|10.42|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-3-"DIAGNOSIS"-noun-0]|TX|[1106/9],[1220/9]|
00000000|MMI|10.42|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-14-"M.D"-noun-0,"M.D."-tx-1-"M.D"-noun-0]|TX|2533/3;275/3|
00000000|MMI|10.42|Requirement|C1514873|[ftcn]|["Required"-tx-2-"Required"-verb-0]|TX|[556/8],[640/8]|
00000000|MMI|10.42|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-15-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|2590/6;43/6|
00000000|MMI|9.99|Observation in research|C0302523|[resa]|["Observation"-tx-8-"observation"-noun-0]|TX|2154/11|E05.581.249
00000000|MMI|9.94|Appointments|C0003629|[idcn]|["Appointment"-tx-3-"APPOINTMENT"-noun-0]|TX|1038/11|N04.452.095
00000000|MMI|9.89|Diet therapy|C0012159|[hlca]|["Diet"-tx-3-"DIET"-noun-0]|TX|940/4|E02.642.249
00000000|MMI|9.86|Stent, device|C0038257|[medd]|["Stent"-tx-3-"stent"-noun-0]|TX|1663/5|E07.695.750
00000000|MMI|9.73|Ischemia|C0022116|[patf]|["Ischaemia, NOS"-tx-10-"ischemia"-noun-1]|TX|2216/8|C23.550.513
00000000|MMI|8.34|Allergic Reaction|C1527304|[patf]|["Allergy"-tx-3-"ALLERGY"-noun-0]|TX|1087/7|C20.543
00000000|MMI|8.34|Hypersensitivity|C0020517|[patf]|["ALLERGY"-tx-3-"ALLERGY"-noun-0]|TX|1087/7|C20.543
00000000|MMI|8.34|Infection|C3714514|[patf]|["Infections"-tx-3-"Infections"-noun-0]|TX|1243/10|C01.539
00000000|MMI|8.34|Work|C0043227|[ocac]|["Working"-tx-8-"working"-verb-0]|TX|2087/7|I03.946
00000000|MMI|8.00|Place|C0442504|[spco]|["Place"-tx-4-"placed"-verb-0,"Place"-tx-3-"placed"-verb-0]|TX|1777/6;1474/6|
00000000|MMI|8.00|Place - dosing instruction imperative|C1704765|[ftcn]|["Place"-tx-4-"placed"-verb-0,"Place"-tx-3-"placed"-verb-0]|TX|1777/6;1474/6|
00000000|MMI|8.00|put - instruction imperative|C1882509|[acty]|["Place"-tx-4-"placed"-verb-0,"Place"-tx-3-"placed"-verb-0]|TX|1777/6;1474/6|
00000000|MMI|7.70|Hospital admission|C0184666|[hlca]|["Admission"-tx-3-"Admission"-noun-0,"Admit"-tx-3-"ADMIT"-verb-0]|TX|1188/9;1100/5|
00000000|MMI|7.61|Condition|C0348080|[qlco]|["Condition"-tx-14-"CONDITION"-noun-0,"Condition"-tx-3-"Conditions"-noun-0]|TX|2413/9;1230/10|
00000000|MMI|7.61|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-14-"CONDITION"-noun-0,"Condition"-tx-3-"Conditions"-noun-0]|TX|2413/9;1230/10|
00000000|MMI|7.61|Logical Condition|C1705253|[cnce]|["Condition"-tx-14-"CONDITION"-noun-0,"Condition"-tx-3-"Conditions"-noun-0]|TX|2413/9;1230/10|
00000000|MMI|7.61|MYOTONIC DYSTROPHY 1|C3250443|[dsyn]|["DM"-tx-12-"DM"-noun-0,"DM"-tx-3-"DM"-noun-0]|TX|2295/2;1297/2|
00000000|MMI|7.53|End|C0444930|[spco]|["End"-tx-15-"END"-noun-0,"End"-tx-2-"END"-verb-0]|TX|2573/3;536/3|
00000000|MMI|7.53|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-15-"END"-noun-0,"End"-tx-2-"END"-verb-0]|TX|2573/3;536/3|
00000000|MMI|7.47|Complication|C0009566|[patf]|["Complications"-tx-3-"Complications"-noun-0,"Complications"-tx-3-"complications"-noun-1]|TX|1256/13;1497/13|
00000000|MMI|7.46|Used by|C1273517|[fndg]|["used"-tx-12-"used"-verb-0,"used"-tx-1-"USED"-verb-0]|TX|2339/4;213/4|
00000000|MMI|7.42|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-14-"Follow up"-adj-0,"FOLLOW-UP"-tx-3-"FOLLOW UP"-adj-0]|TX|2443/9;1028/9|
00000000|MMI|7.42|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-14-"Follow up"-adj-0,"Follow-Up"-tx-3-"FOLLOW UP"-adj-0]|TX|2443/9;1028/9|
00000000|MMI|7.42|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-14-"Follow up"-adj-0,"Follow-up"-tx-3-"FOLLOW UP"-adj-0]|TX|2443/9;1028/9|
00000000|MMI|7.42|Post-Procedure|C3272301|[tmco]|["Post-Procedure"-tx-8-"post procedure"-adj-0,"Post-Procedure"-tx-6-"post procedure"-adj-0]|TX|2123/14;1983/14|
00000000|MMI|7.42|follow-up|C1522577|[hlca]|["Follow Up"-tx-14-"Follow up"-adj-0,"Follow Up"-tx-3-"FOLLOW UP"-adj-0]|TX|2443/9;1028/9|
00000000|MMI|7.26|Summary (document)|C1706244|[inpr]|["Summary"-tx-14-"summary"-noun-0,"Summary"-tx-1-"SUMMARY"-noun-0]|TX|2491/7;229/7|
00000000|MMI|7.26|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-14-"summary"-noun-0,"summary"-tx-1-"SUMMARY"-noun-0]|TX|2491/7;229/7|
00000000|MMI|7.24|Dose number|C1115464|[qnco]|["Dose number"-tx-2-"Number Doses"-noun-0]|TX|[540/6,550/5],[624/6,634/5]|
00000000|MMI|7.24|Dose number:Number:Point in time:^Patient:Quantitative|C1114758|[clna]|["Dose number"-tx-2-"Number Doses"-noun-0]|TX|[540/6,550/5],[624/6,634/5]|
00000000|MMI|7.16|Status|C0449438|[qlco]|["Status"-tx-5-"STATUS"-noun-0,"Status"-tx-2-"STATUS"-noun-0]|TX|1800/6;285/6|
00000000|MMI|7.13|House (environment)|C2003847|[mnob]|["House"-tx-12-"house"-adj-0,"House"-tx-3-"House"-noun-0]|TX|2329/5;946/5|
00000000|MMI|7.10|Plain chest X-ray|C0039985|[diap]|["cxr"-tx-8-"cxr"-noun-0,"cxr"-tx-6-"CXR"-noun-0]|TX|2168/3;1962/3|
00000000|MMI|7.09|Attending (action)|C1999232|[ftcn]|["attending"-tx-1-"Attending"-adj-0,"attending"-tx-1-"Attending"-noun-0]|TX|[174/9],[242/9];[174/9],[242/9]|
00000000|MMI|7.09|Attending (provider role)|C1547429|[prog]|["Attending"-tx-1-"Attending"-adj-0,"Attending"-tx-1-"Attending"-noun-0]|TX|[174/9],[242/9];[174/9],[242/9]|
00000000|MMI|7.09|Infusion pump Alert priority PM|C4049155|[fndg]|["PM"-tx-15-"PM"-noun-0,"PM"-tx-1-"PM"-adj-0]|TX|2563/2;155/2|
00000000|MMI|7.08|Plavix|C0633084|[orch,phsu]|["Plavix"-tx-10-"plavix"-noun-0,"Plavix"-tx-2-"PLAVIX"-noun-0]|TX|2247/6;668/6|
00000000|MMI|7.04|Active|C0205177|[ftcn]|["Active"-tx-10-"active"-adj-0,"Activity"-tx-3-"ACTIVITY"-noun-0]|TX|2209/6;997/8|
00000000|MMI|7.02|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-13-"resume"-noun-0,"Resume"-tx-3-"RESUME"-noun-0]|TX|2359/6;1566/6|
00000000|MMI|7.02|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-13-"resume"-noun-0,"Resume"-tx-3-"RESUME"-noun-0]|TX|2359/6;1566/6|
00000000|MMI|7.02|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-13-"resume"-noun-0,"resume"-tx-3-"RESUME"-noun-0]|TX|2359/6;1566/6|
00000000|MMI|7.02|Code|C0805701|[inpr]|["CODE"-tx-2-"CODE"-noun-0,"CODE"-tx-2-"code"-noun-0]|TX|280/4;298/4|
00000000|MMI|7.02|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-2-"CODE"-noun-0,"Code"-tx-2-"code"-noun-0]|TX|280/4;298/4|
00000000|MMI|7.01|Bradycardia by ECG Finding|C3812171|[fndg]|["BRADYCARDIA"-tx-7-"BRADYCARDIA"-noun-0,"BRADYCARDIA"-tx-3-"bradycardia"-noun-0]|TX|2037/11;1759/11|
00000000|MMI|6.95|50%|C3842586|[fndg]|["50%"-tx-2-"50"-integer-0]|TX|[448/2],[744/2]|
00000000|MMI|6.95|<50|C3843766|[fndg]|["<50"-tx-2-"50"-integer-0]|TX|[448/2],[744/2]|
00000000|MMI|6.92|Subject Continuance|C2826258|[evnt]|["CONT"-tx-10-"cont"-noun-0,"CONT"-tx-8-"cont"-noun-0]|TX|2227/4;2102/4|
00000000|MMI|6.90|MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME|C3280240|[dsyn]|["MEDS"-tx-13-"meds"-noun-0,"MEDS"-tx-10-"meds"-noun-1]|TX|2366/4;2237/4|
00000000|MMI|6.75|Educational process of instructing|C0039401|[edac]|["Instruction"-tx-2-"Instruction"-noun-0]|TX|778/11|I02.903
00000000|MMI|6.61|Bandage|C0004726|[medd]|["BANDAGE"-tx-5-"bandage"-noun-0]|TX|1939/7|E07.101
00000000|MMI|5.18|ARID1A wt Allele|C2985160|[gngm]|["hELD"-tx-12-"held"-verb-0]|TX|2302/4|
00000000|MMI|5.18|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-3-"OPERATIONS"-noun-0]|TX|1443/10|
00000000|MMI|5.18|Additional comments|C1830770|[fndg]|["Additional comments"-tx-14-"ADDITIONAL COMMENTS"-noun-0]|TX|2382/19|
00000000|MMI|5.18|Affecting|C0392760|[ftcn]|["Affecting"-tx-3-"affecting"-verb-0]|TX|1272/9|
00000000|MMI|5.18|Alexandra|C1932661|[plnt]|["Alexandra"-tx-1-"ALEXANDRA"-noun-0]|TX|263/9|
00000000|MMI|5.18|Allergic disposition|C3539909|[dsyn]|["Allergy"-tx-3-"ALLERGY"-noun-0]|TX|1087/7|
00000000|MMI|5.18|Allergy - Physicians|C1554743|[prog]|["Allergy"-tx-3-"ALLERGY"-noun-0]|TX|1087/7|
00000000|MMI|5.18|Appearance|C0700364|[qlco]|["APPEAR"-tx-8-"appears"-verb-0]|TX|2073/7|
00000000|MMI|5.18|Arikaree language|C1555622|[lang]|["Ris"-tx-12-"RISS"-noun-0]|TX|2346/4|
00000000|MMI|5.18|Arylsulfatase A, human|C3853627|[aapp,enzy]|["ASA"-tx-10-"asa"-noun-0]|TX|2256/3|
00000000|MMI|5.18|Bounded by|C0332297|[spco]|["BB"-tx-10-"bb"-noun-0]|TX|2280/2|
00000000|MMI|5.18|C-Circle|C3538933|[celc]|["CC"-tx-3-"CC"-noun-0]|TX|1593/2|
00000000|MMI|5.18|CALD1 wt Allele|C3813548|[gngm]|["CAD"-tx-3-"CAD"-noun-0]|TX|1350/3|
00000000|MMI|5.18|CETRIMONIUM BROMIDE|C0951233|[hops,orch]|["CTAB"-tx-5-"ctab"-noun-0]|TX|1895/4|
00000000|MMI|5.18|Complete Response with Incomplete Bone Marrow Recovery|C3538993|[fndg]|["CRi"-tx-3-"CRI"-noun-0]|TX|1382/3|
00000000|MMI|5.18|Cranial Rhythmic Impulse|C1704519|[phsf]|["CRI"-tx-3-"CRI"-noun-0]|TX|1382/3|
00000000|MMI|5.18|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|5.18|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|0/14|
00000000|MMI|5.18|Donepezil hydrochloride|C0771848|[orch,phsu]|["donepezil hcl"-tx-2-"DONEPEZIL HCL"-noun-0]|TX|595/13|
00000000|MMI|5.18|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-3-"OPERATIONS"-noun-0]|TX|1443/10|
00000000|MMI|5.18|Held - activity status|C1948036|[idcn]|["held"-tx-12-"held"-verb-0]|TX|2302/4|
00000000|MMI|5.18|Hypertension Adverse Event|C1963138|[fndg]|["Hypertension"-tx-3-"hypertension"-noun-0]|TX|1335/12|
00000000|MMI|5.18|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-3-"PROCEDURES"-noun-0]|TX|1458/10|
00000000|MMI|5.18|Involvement with|C1314939|[ftcn]|["Affecting"-tx-3-"affecting"-verb-0]|TX|1272/9|
00000000|MMI|5.18|Laboratory Procedures|C0022885|[lbpr]|["Tests"-tx-6-"TESTS"-noun-0]|TX|1955/5|
00000000|MMI|5.18|Mild dementia|C3494623|[mobd]|["Mild dementia"-tx-3-"mild dementia"-noun-0]|TX|1416/13|
00000000|MMI|5.18|PROBLEM LIST|C0552582|[inpr]|["PROBLEM LIST"-tx-6-"PROBLEM LIST"-noun-0]|TX|2007/12|
00000000|MMI|5.18|Presenile dementia|C0011265|[mobd]|["dementia"-tx-3-"dementia"-noun-0]|TX|1432/8|
00000000|MMI|5.18|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-3-"PROCEDURES"-noun-0]|TX|1458/10|
00000000|MMI|5.18|RASL12 gene|C1428956|[gngm]|["RIS"-tx-12-"RISS"-noun-0]|TX|2346/4|
00000000|MMI|5.18|RNH1 gene|C1826843|[gngm]|["CRI"-tx-3-"CRI"-noun-0]|TX|1382/3|
00000000|MMI|5.18|Response to antigens|C1314973|[phsf]|["ALLERGY"-tx-3-"ALLERGY"-noun-0]|TX|1087/7|
00000000|MMI|5.18|S prime|C2603362|[clna]|["S'"-tx-3-"("-noun-0]|TX|1049/1|
00000000|MMI|5.18|TAC1 wt Allele|C1705924|[gngm]|["NKA"-tx-3-"NKA"-noun-0]|TX|1096/3|
00000000|MMI|5.18|Take|C1515187|[hlca]|["Take"-tx-2-"Take"-verb-0]|TX|790/4|
00000000|MMI|5.18|Tests (qualifier value)|C0392366|[inpr]|["Tests"-tx-6-"TESTS"-noun-0]|TX|1955/5|
00000000|MMI|5.18|To|C1883351|[qlco]|["To"-tx-8-"to"-adv-0]|TX|2081/2|
00000000|MMI|5.18|atorvastatin|C0286651|[orch,phsu]|["ATORVASTATIN"-tx-3-"ATORVASTATIN"-noun-0]|TX|851/12|
00000000|MMI|5.18|per second|C0565930|[qnco]|["/s"-tx-3-"("-noun-0]|TX|1049/1|
00000000|MMI|5.18|problem list - observation|C1553895|[inpr]|["problem list"-tx-6-"PROBLEM LIST"-noun-0]|TX|2007/12|
00000000|MMI|5.18|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-3-"TREATMENTS/PROCEDURES"-noun-0]|TX|1517/21|
00000000|MMI|4.12|Oral hypoglycemic|C0359086|[phsu]|["Oral hypoglycemic"-tx-12-"oral hypoglycemics"-noun-0]|TX|2307/18|
00000000|MMI|3.98|Beginning|C0439659|[tmco]|["Start"-tx-2-"Starting"-verb-0]|TX|507/8|
00000000|MMI|3.78|g.m|C0456715|[qnco]|["m g"-tx-5-"m g"-noun-0]|TX|1887/1,1891/1|
00000000|MMI|3.75|MR vaccine|C0694746|[imft,phsu]|["M/R"-tx-5-"m/r"-noun-0]|TX|1887/3|
00000000|MMI|3.75|Medication.discharge|C0806915|[fndg]|["Discharge medications"-tx-2-"DISCHARGE MEDICATIONS"-noun-0]|TX|321/21|
00000000|MMI|3.75|Renal dysfunction|C3279454|[fndg]|["Renal dysfunction"-tx-3-"renal dysfunction"-noun-0]|TX|1396/17|
00000000|MMI|3.70|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-3-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|1121/9,1141/9|
00000000|MMI|3.70|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-3-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|1121/9,1141/9|
00000000|MMI|3.68|Admission activity|C0809949|[hlca]|["Admission"-tx-3-"Admission"-noun-0]|TX|1188/9|
00000000|MMI|3.68|Antibiotic throat preparations|C3540706|[antb]|["Antibiotics"-tx-2-"ANTIBIOTICS"-noun-0]|TX|524/11|
00000000|MMI|3.68|Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE|C3540707|[antb]|["Antibiotics"-tx-2-"ANTIBIOTICS"-noun-0]|TX|524/11|
00000000|MMI|3.68|Antibiotics for systemic use|C3540704|[antb]|["Antibiotics"-tx-2-"ANTIBIOTICS"-noun-0]|TX|524/11|
00000000|MMI|3.68|Antibiotics, Gynecological|C3540708|[antb]|["Antibiotics"-tx-2-"ANTIBIOTICS"-noun-0]|TX|524/11|
00000000|MMI|3.68|Antibiotics, ophthalmologic|C3540710|[antb]|["Antibiotics"-tx-2-"ANTIBIOTICS"-noun-0]|TX|524/11|
00000000|MMI|3.68|Antifungal Antibiotics, Topical|C3540705|[antb]|["Antibiotics"-tx-2-"ANTIBIOTICS"-noun-0]|TX|524/11|
00000000|MMI|3.68|Aricept|C0527315|[orch,phsu]|["Aricept"-tx-2-"ARICEPT"-noun-0]|TX|585/7|
00000000|MMI|3.68|Clear|C2963144|[qlco]|["Clear"-tx-6-"clear"-adj-0]|TX|1968/5|
00000000|MMI|3.68|Coating (film)|C1522408|[qlco]|["Coated"-tx-2-"COATED"-adj-0]|TX|368/6|
00000000|MMI|3.68|Enteral|C1304890|[spco]|["Enteric"-tx-2-"ENTERIC"-adj-0]|TX|360/7|
00000000|MMI|3.68|Negative Surgical Margin|C1709157|[fndg]|["Clear"-tx-6-"clear"-adj-0]|TX|1968/5|
00000000|MMI|3.68|Observation - diagnostic procedure|C1964257|[diap]|["OBSERVATION"-tx-8-"observation"-noun-0]|TX|2154/11|
00000000|MMI|3.68|antibiotics, intestinal|C3540709|[antb]|["Antibiotics"-tx-2-"ANTIBIOTICS"-noun-0]|TX|524/11|
00000000|MMI|3.68|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-3-"DISCHARGE DIAGNOSIS"-noun-0]|TX|1131/19|
00000000|MMI|3.68|Arm sling|C0183347|[medd]|["Sling - arm"-tx-5-"arm sling"-noun-0]|TX|1813/3,1820/5|
00000000|MMI|3.64|Entered|C1521975|[qlco]|["Entered"-tx-14-"ENTERED"-verb-0]|TX|2499/7|
00000000|MMI|3.63|Disposition|C0743223|[idcn]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|303/11|
00000000|MMI|3.63|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|303/11|
00000000|MMI|3.63|Distal|C0205108|[spco]|["DISTAL"-tx-5-"distal"-adj-0]|TX|1911/6|
00000000|MMI|3.63|Gram per Deciliter|C0439267|[qnco]|["g%"-tx-5-"g"-noun-0]|TX|1891/1|
00000000|MMI|3.63|Medical Examination|C0582103|[hlca]|["Exam"-tx-5-"EXAM"-noun-0]|TX|1807/4|
00000000|MMI|3.63|Physiologic pulse|C0391850|[phsf]|["PULSES"-tx-5-"pulses"-noun-1]|TX|1918/6|
00000000|MMI|3.61|*Activity (kind of quantity)|C1561536|[idcn]|["*Activity"-tx-3-"ACTIVITY"-noun-0]|TX|997/8|
00000000|MMI|3.61|Activities|C0441655|[acty]|["ACTIVITY"-tx-3-"ACTIVITY"-noun-0]|TX|997/8|
00000000|MMI|3.61|Activity (animal life circumstance)|C3668946|[fndg]|["Activity"-tx-3-"ACTIVITY"-noun-0]|TX|997/8|
00000000|MMI|3.61|FDA Establishment Activity Terminology|C4049939|[inpr]|["ACTIVITY"-tx-3-"ACTIVITY"-noun-0]|TX|997/8|
00000000|MMI|3.61|Percent Activity|C0439167|[qnco]|["% Activity"-tx-3-"ACTIVITY"-noun-0]|TX|997/8|
00000000|MMI|3.61|Physical Activity Measurement|C4049938|[lbpr]|["ACTIVITY"-tx-3-"ACTIVITY"-noun-0]|TX|997/8|
00000000|MMI|3.61|Planned|C1301732|[ftcn]|["Plan"-tx-14-"PLAN"-noun-0]|TX|2437/4|
00000000|MMI|3.61|Standard (document)|C2828392|[inpr]|["Standard"-tx-8-"standard"-noun-0]|TX|2107/8|
00000000|MMI|3.61|Standard (qualifier)|C1442989|[qlco]|["Standard"-tx-8-"standard"-noun-0]|TX|2107/8|
00000000|MMI|3.61|Treatment Plan|C0599880|[inpr]|["Plan"-tx-14-"PLAN"-noun-0]|TX|2437/4|
00000000|MMI|3.61|care activity|C1947933|[acty]|["Care"-tx-8-"care"-noun-0]|TX|2116/4|
00000000|MMI|3.60|Keflex|C0700517|[antb,orch]|["Keflex"-tx-2-"KEFLEX"-noun-0]|TX|460/6|
00000000|MMI|3.60|week|C0439230|[tmco]|["WEEKS"-tx-3-"weeks"-noun-0]|TX|1079/5|
00000000|MMI|3.60|Blood group antibody I|C0221138|[aapp,imft]|["I NOS"-tx-5-"I"-noun-0]|TX|1951/1|
00000000|MMI|3.59|Dosage|C0178602|[qnco]|["Doses"-tx-2-"doses"-noun-0]|TX|501/5|
00000000|MMI|3.59|Instruction [Publication Type]|C0302828|[inpr]|["Instruction"-tx-2-"Instruction"-noun-0]|TX|778/11|
00000000|MMI|3.59|Instructions|C1442085|[idcn]|["instruction"-tx-2-"Instruction"-noun-0]|TX|778/11|
00000000|MMI|3.59|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-1-"Service"-noun-0]|TX|103/7|
00000000|MMI|3.59|Services|C0557854|[ocac]|["Service"-tx-1-"Service"-noun-0]|TX|103/7|
00000000|MMI|3.59|Software Service|C2825316|[mnob]|["Service"-tx-1-"Service"-noun-0]|TX|103/7|
00000000|MMI|3.59|Arranged (transportation)|C1546854|[idcn]|["Arranged"-tx-14-"arranged"-verb-0]|TX|2456/8|
00000000|MMI|3.59|Cardiology service|C3887620|[hcro]|["Cardiology"-tx-14-"cardiology"-noun-0]|TX|2468/10|
00000000|MMI|3.59|Responsible to|C1273518|[fndg]|["Responsible"-tx-3-"Responsible"-adj-0]|TX|1152/11|
00000000|MMI|3.59|Surgical transfer - action|C0348011|[ftcn]|["transferred"-tx-3-"transferred"-verb-0]|TX|1705/11|
00000000|MMI|3.59|TH gene|C1420718|[gngm]|["TH"-tx-3-"TH"-noun-0]|TX|1722/2|
00000000|MMI|3.59|Transfer Technique|C1705822|[ftcn]|["Transferred"-tx-3-"transferred"-verb-0]|TX|1705/11|
00000000|MMI|3.59|Basal Diet|C2983588|[food]|["DIET"-tx-3-"DIET"-noun-0]|TX|940/4|
00000000|MMI|3.59|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-3-"DIET"-noun-0]|TX|940/4|
00000000|MMI|3.59|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-3-"DIET"-noun-0]|TX|940/4|
00000000|MMI|3.57|Empty (qualifier)|C1880497|[qlco]|["Empty"-tx-2-"empty"-adj-0]|TX|825/5|
00000000|MMI|3.57|Entire stomach|C1278920|[bpoc]|["Stomach"-tx-2-"stomach"-noun-0]|TX|831/7|
00000000|MMI|3.57|Gastric Tissue|C1517454|[tisu]|["STOMACH"-tx-2-"stomach"-noun-0]|TX|831/7|
00000000|MMI|3.57|Negation|C1518422|[ftcn]|["Not"-tx-3-"NOT"-adv-0]|TX|1541/3|
00000000|MMI|3.57|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-13-"Pt"-noun-0]|TX|2353/2|
00000000|MMI|3.57|Physical therapy (field)|C0699718|[bmod]|["PT"-tx-13-"Pt"-noun-0]|TX|2353/2|
00000000|MMI|3.57|Stomach structure|C3714551|[bpoc]|["Stomach"-tx-2-"stomach"-noun-0]|TX|831/7|
00000000|MMI|3.55|Conditional|C1701901|[qlco]|["Contingent"-tx-1-"CONTINGENT"-noun-0]|TX|158/10|
00000000|MMI|3.55|Stent Device Component|C1705817|[medd]|["Stent"-tx-3-"stent"-noun-0]|TX|1663/5|
00000000|MMI|3.54|Evidence|C3887511|[idcn]|["Evidence"-tx-10-"evidence"-noun-0]|TX|2197/8|
00000000|MMI|3.53|Discontinued|C1444662|[fndg]|["D/C"-tx-1-"D/C"-noun-0]|TX|200/3|
00000000|MMI|3.53|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-1-"D/C"-noun-0]|TX|200/3|
00000000|MMI|3.50|20%|C3842589|[fndg]|["20%"-tx-2-"20"-integer-0]|TX|582/2|
00000000|MMI|3.50|23|C0450348|[qnco]|["23"-tx-15-"23"-integer-0]|TX|2560/2|
00000000|MMI|3.50|Causing|C0678227|[ftcn]|["Causing"-tx-3-"Causing"-adj-0]|TX|1180/7|
00000000|MMI|3.50|Easy|C0332219|[qlco]|["Easily"-tx-5-"easily"-adv-0]|TX|1845/6|
00000000|MMI|3.50|High dose|C0444956|[qnco]|["High dose"-tx-10-"highdose"-adj-0]|TX|2262/8|
00000000|MMI|3.50|Overnight|C0439583|[tmco]|["Overnight"-tx-8-"overnight"-adj-0]|TX|2144/9|
00000000|MMI|3.50|Yes (indicator)|C1705108|[cnce]|["YES"-tx-1-"YES"-noun-0]|TX|238/3|
00000000|MMI|3.50|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-1-"YES"-noun-0]|TX|238/3|
00000000|MMI|3.50|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-14-"dictated"-adj-0]|TX|2482/8|
00000000|MMI|3.50|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-14-"dictated"-adj-0]|TX|2482/8|
00000000|MMI|3.49|mg/mg|C1319635|[qnco]|["mg/mg"-tx-3-"MG MG"-noun-0]|TX|907/2,931/2|
00000000|MMI|3.48|2/5|C0450346|[qnco]|["2 5"-tx-2-"2.5"-real_number-0]|TX|413/3|
00000000|MMI|3.48|Administration procedure|C1533734|[topp]|["Treatment"-tx-3-"Treatment"-noun-0]|TX|1282/9|
00000000|MMI|3.48|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-3-"Treatment"-noun-0]|TX|1282/9|
00000000|MMI|3.48|Full|C0443225|[qlco]|["Full"-tx-2-"Full"-adj-0]|TX|293/4|
00000000|MMI|3.48|Residual|C1609982|[qlco]|["Residual"-tx-3-"residual"-adj-0]|TX|1687/8|
00000000|MMI|3.48|Therapeutic procedure|C0087111|[topp]|["Treatment"-tx-3-"Treatment"-noun-0]|TX|1282/9|E02
00000000|MMI|3.48|Treating|C1522326|[ftcn]|["Treatment"-tx-3-"Treatment"-noun-0]|TX|1282/9|
00000000|MMI|3.48|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-3-"Treatment"-noun-0]|TX|1282/9|
00000000|MMI|3.48|chronic|C0205191|[tmco]|["CHRONIC"-tx-3-"chronic"-adj-0]|TX|1388/7|
00000000|MMI|3.48|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-3-"Treatment"-noun-0]|TX|1282/9|
00000000|MMI|3.47|Complete atrioventricular block|C0151517|[dsyn]|["chb"-tx-3-"CHB"-noun-0]|TX|1117/3|
00000000|MMI|3.47|Gender Status - Intact|C1554187|[fndg]|["Intact"-tx-5-"intact"-adj-0]|TX|1866/6|
00000000|MMI|3.47|Good|C0205170|[qlco]|["Well"-tx-8-"well"-adv-0]|TX|2095/4|
00000000|MMI|3.47|Intact|C0205266|[qlco]|["Intact"-tx-5-"intact"-adj-0]|TX|1866/6|
00000000|MMI|3.47|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-14-"Stable"-adj-0]|TX|2424/6|
00000000|MMI|3.47|Primary|C0205225|[qlco]|["Principal"-tx-3-"PRINCIPAL"-adj-0]|TX|1121/9|
00000000|MMI|3.47|Sodium Cation|C0597484|[elii]|["Sodium+"-tx-3-"Sodium"-noun-0]|TX|990/6|
00000000|MMI|3.47|Sodium Drug Class|C3714642|[phsu]|["SODIUM"-tx-3-"Sodium"-noun-0]|TX|990/6|
00000000|MMI|3.47|Sodium supplements|C3541959|[phsu]|["Sodium"-tx-3-"Sodium"-noun-0]|TX|990/6|
00000000|MMI|3.47|Stable status|C0205360|[qlco]|["STABLE"-tx-14-"Stable"-adj-0]|TX|2424/6|
00000000|MMI|3.47|Teaching principal|C0401925|[prog]|["Principal"-tx-3-"PRINCIPAL"-adj-0]|TX|1121/9|
00000000|MMI|3.47|Well|C3146287|[mnob]|["Well"-tx-8-"well"-adv-0]|TX|2095/4|
00000000|MMI|3.47|gram|C0439208|[qnco]|["GRAM"-tx-3-"gram"-noun-0]|TX|985/4|
00000000|MMI|3.46|80%|C3842583|[fndg]|["80%"-tx-3-"80"-integer-0]|TX|866/2|
00000000|MMI|3.46|Cardiologist|C0175906|[prog]|["Cardiologist"-tx-3-"cardiologist"-noun-0]|TX|1062/12|
00000000|MMI|3.46|Local|C0205276|[spco]|["LOCAL"-tx-3-"Local"-adj-0]|TX|1056/5|
00000000|MMI|3.46|Anatomic Site|C1515974|[blor]|["Site"-tx-5-"site"-noun-0]|TX|1934/4|
00000000|MMI|3.46|Bandage Dosage Form|C2346961|[bodm]|["Bandage"-tx-5-"bandage"-noun-0]|TX|1939/7|
00000000|MMI|3.46|Site|C0205145|[spco]|["Site"-tx-5-"site"-noun-0]|TX|1934/4|
00000000|MMI|3.46|Study Site|C2825164|[spco]|["Site"-tx-5-"site"-noun-0]|TX|1934/4|
00000000|MMI|3.45|Cholesterol measurement test|C0201950|[lbpr]|["CHOL"-tx-3-"chol"-noun-0]|TX|958/4|
00000000|MMI|3.45|Four times daily|C0585291|[tmco]|["QID"-tx-2-"QID"-adv-0]|TX|492/3|
00000000|MMI|3.45|SAT1 protein, human|C2744672|[aapp,enzy]|["SAT"-tx-3-"sat"-noun-0]|TX|967/3|
00000000|MMI|3.45|SAT1 wt Allele|C1705827|[gngm]|["SAT"-tx-3-"sat"-noun-0]|TX|967/3|
00000000|MMI|3.45|0%|C3842591|[fndg]|["0%"-tx-1-"0"-integer-0]|TX|85/1|
00000000|MMI|3.45|68|C0450387|[inpr]|["68"-tx-1-"68"-integer-0]|TX|79/2|
00000000|MMI|3.45|K Prime|C1708601|[qnco]|["K'"-tx-1-"K"-noun-0]|TX|73/1|
00000000|MMI|3.45|Potassium Ion|C0597277|[elii,phsu]|["K+"-tx-1-"K"-noun-0]|TX|73/1|
00000000|MMI|3.45|TFPI gene|C1420705|[gngm]|["LACI"-tx-1-"LACI"-noun-0]|TX|68/4|
00000000|MMI|3.45|TFPI wt Allele|C3273314|[gngm]|["LACI"-tx-1-"LACI"-noun-0]|TX|68/4|
00000000|MMI|3.45|Tissue factor pathway inhibitor|C0164707|[aapp,phsu]|["LACI"-tx-1-"LACI"-noun-0]|TX|68/4|
00000000|MMI|3.45|Hospital course|C0489547|[fndg]|["Hospital course"-tx-3-"HOSPITAL COURSE"-noun-1]|TX|1576/15|
00000000|MMI|3.45|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-3-"HOSPITAL COURSE"-noun-0]|TX|1576/15|
00000000|MMI|3.45|Room of building - Study|C0557651|[mnob]|["Study"-tx-3-"Study"-noun-0]|TX|1170/5|
00000000|MMI|3.45|Study|C2603343|[resa]|["Study"-tx-3-"Study"-noun-0]|TX|1170/5|
00000000|MMI|3.44|CXADR wt Allele|C3540475|[gngm]|["CAR"-tx-1-"CAR"-noun-0]|TX|112/3|
00000000|MMI|3.44|Coxsackievirus and Adenovirus Receptor|C3539542|[aapp]|["CAR"-tx-1-"CAR"-noun-0]|TX|112/3|
00000000|MMI|3.44|NR1I3 wt Allele|C3811749|[gngm]|["CAR"-tx-1-"CAR"-noun-0]|TX|112/3|
00000000|MMI|3.43|100%|C3817553|[qnco]|["100%"-tx-3-"100"-percentage-0]|TX|1672/3|
00000000|MMI|3.43|Behavior Rating Inventory of Executive Function|C4050216|[inpr]|["BRIEF"-tx-3-"BRIEF"-adj-0]|TX|1560/5|
00000000|MMI|3.43|Brief|C1879313|[tmco]|["Brief"-tx-3-"BRIEF"-adj-0]|TX|1560/5|
00000000|MMI|3.43|Evaluation procedure|C1261322|[hlca]|["Evaluation"-tx-1-"evaluation"-noun-0]|TX|184/10|
00000000|MMI|3.43|Following|C0332282|[tmco]|["Subsequent"-tx-3-"subsequent"-adj-0]|TX|1652/10|
00000000|MMI|3.43|Shortened|C1282927|[qlco]|["brief"-tx-3-"BRIEF"-adj-0]|TX|1560/5|
00000000|MMI|3.43|Symptomatic|C0231220|[ftcn]|["Symptomatic"-tx-3-"symptomatic"-adj-0]|TX|1747/11|
00000000|MMI|3.42|10%|C3842590|[fndg]|["10%"-tx-2-"10"-integer-0]|TX|611/2|
00000000|MMI|3.42|Every e